Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes: A Randomized 3-month Clinical Trial Using a Sequential Parallel Comparison Design

NCT03818581 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03818581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03818581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes: A Randomized 3-month Clinical Trial Using a Sequential Parallel Comparison Design
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2019
Completion date
November 3, 2021
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, insomnia, sleep disorder, type 2 diabetes mellitus